Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, double-blind, placebo-controlled Phase 2 trial of evaluating safety and efficacy of different doses and ratios of Cannabis Oil to improve uncontrolled chronic pain in cancer and non-cancer patients

Trial Profile

A randomized, double-blind, placebo-controlled Phase 2 trial of evaluating safety and efficacy of different doses and ratios of Cannabis Oil to improve uncontrolled chronic pain in cancer and non-cancer patients

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jun 2018

At a glance

  • Drugs Marijuana (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jun 2018 According to a Tetra Bio-Pharma media release, Dr. Antonio Vigano is the Principal Investigator in this trial.
    • 18 Jun 2018 According to a Tetra Bio-Pharma media release, status changed from not yet recruiting to recruiting.
    • 01 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top